Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19
Keywords
Abstract
Description
Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients:
Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation.
Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin.
Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.
Dates
| Last Verified: | 06/30/2020 |
| First Submitted: | 07/19/2020 |
| Estimated Enrollment Submitted: | 07/26/2020 |
| First Posted: | 07/28/2020 |
| Last Update Submitted: | 07/26/2020 |
| Last Update Posted: | 07/28/2020 |
| Actual Study Start Date: | 06/30/2020 |
| Estimated Primary Completion Date: | 08/31/2020 |
| Estimated Study Completion Date: | 08/31/2020 |
Condition or disease
Intervention/treatment
Diagnostic Test: Patients with Covid-19
Phase
Arm Groups
| Arm | Intervention/treatment |
|---|---|
| Patients with Covid-19 COVID-19 patients presented with gastrointestinal manifestations | Diagnostic Test: Patients with Covid-19 Laboratory tests such as CBC, Liver function and CRP |
Eligibility Criteria
| Sexes Eligible for Study | All |
| Sampling method | Probability Sample |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: - Confirmed Covid-19 with GIT manifestations Exclusion Criteria: - Patients refuse to participate |
Outcome
Primary Outcome Measures
1. Clinical data questionnaire [2 months]
2. Tests such as CBC [2 months]
3. liver function test [2 months]
